Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma

Diffuse Large B cell lymphomas (DLBCL) are the most prevalent of the non-Hodgkin lymphomas and are currently initially treated fairly successfully, but frequently relapse as refractory disease, resulting in poor salvage therapy options and short survival. The greatest challenge in improving survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Changping, Thompson, Michael A., Tamayo, Archito T., Zuo, Zhuang, Lee, John, Vega, Francisco, Ford, Richard J., Pham, Lan V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359887/
https://www.ncbi.nlm.nih.gov/pubmed/22447839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359887/
https://www.ncbi.nlm.nih.gov/pubmed/22447839

Ejemplares similares